For sterile surgical gloves, the commonly required sterility assurance level is SAL 10⁻⁶. This means the validated sterilization process is designed so that the probability of a viable microorganism remaining on a sterilized item is no greater than one in one million.

The US FDA specifically states in its medical glove guidance that sterilization of medical gloves should meet an SAL of 10⁻⁶.

For hospitals, distributors, and private-label surgical glove programs, however, confirming “SAL 10⁻⁶” on a specification sheet is only the beginning. The sterilization method, process validation, packaging integrity, routine monitoring, and shelf-life evidence all need to support the sterile claim.

What Does SAL 10⁻⁶ Actually Mean?

SAL, or Sterility Assurance Level, is a probability-based measure used for terminally sterilized medical devices.

An SAL of:

10⁻⁶

means a probability of no more than one viable microorganism occurring on one sterilized item in one million.

This should not be interpreted as permission for one visibly contaminated glove in every million units. Sterility cannot be proven by testing every finished glove. Instead, manufacturers establish a validated sterilization process and demonstrate that it consistently achieves the required level of microbial inactivation.

ISO defines SAL as the probability of a single viable microorganism occurring on an item after sterilization.

Why Surgical Gloves Require a High Sterility Assurance Level

Surgical gloves are used in procedures where they can directly contact the surgical field. Unlike non-sterile examination gloves, they must provide both a physical barrier and a controlled sterile condition at the point of use.

A failure in sterility can create a contamination risk even when the glove has acceptable:

• Tensile strength
• Thickness
• Freedom from holes
• Fit
• Packaging appearance

For this reason, surgical glove quality control cannot stop at pinhole testing or physical-property inspection.

Sterility must be established through a validated sterilization process.

Which Sterilization Methods Can Be Used?

Surgical gloves may be sterilized using methods such as:

• Gamma irradiation
• Electron-beam irradiation
• Ethylene oxide, where appropriate and validated

The correct method depends on glove material, packaging, manufacturing process, and regulatory requirements.

FDA guidance notes that sterilization should be performed using a validated method and that the process should not adversely affect glove safety or effectiveness.

This point is important because surgical glove materials can respond differently to sterilization.

A process that achieves microbial reduction but causes excessive aging, brittleness, discoloration, loss of elasticity, or packaging damage is not an acceptable solution.

Radiation Sterilization and SAL 10⁻⁶

For radiation-sterilized medical devices, ISO 11137 is an important reference.

ISO 11137-2 provides methods for establishing radiation doses capable of achieving an SAL of 10⁻⁶ and for performing dose audits to demonstrate that the validated sterilization dose continues to remain effective.

This is why a quotation simply stating:

Gamma sterilized

does not provide enough information for a surgical glove procurement program.

Additional questions should include:

• Is the sterilization process validated?
• What SAL is claimed?
• Which validation standard is used?
• Is routine dose monitoring performed?
• Are periodic dose audits conducted?
• Has glove performance been assessed after sterilization?

An FDA 510(k) record for a sterile latex surgeon’s glove, for example, describes gamma irradiation used to achieve an SAL of 10⁻⁶ and packaging designed to maintain sterility during the product shelf life.

Ethylene Oxide Sterilization Requires Additional Controls

Ethylene oxide, or EO, can also be used for medical-device sterilization where appropriate.

ISO 11135 establishes requirements for development, validation, and routine control of EO sterilization processes for medical devices.

For EO-sterilized products, sterilization validation is only part of the requirement. Residual EO and related substances must also be controlled because they can remain on the product after processing.

For surgical glove sourcing, an EO sterilization package may therefore require review of:

• Validated sterilization cycle
• SAL
• Aeration process
• EO residual testing
• Packaging compatibility
• Product performance after sterilization

The method should be confirmed before bulk production rather than changed after the finished glove and packaging have already been approved.

Sterility Testing Alone Is Not Enough

One common misunderstanding is that passing a finished-product sterility test proves an SAL of 10⁻⁶.

It does not.

Finished-product testing examines only a limited sample. An SAL claim is primarily supported by a validated and routinely controlled sterilization process.

For procurement purposes, this means a supplier should be able to provide evidence related to the sterilization process, not simply a microbiology test result from several glove packs.

Important documents may include:

• Sterilization validation information
• Applicable ISO standard
• Routine sterilization records
• Lot identification
• Release documentation
• Packaging validation
• Shelf-life documentation

The Sterile Barrier Package Is Part of Sterility Assurance

Achieving SAL 10⁻⁶ at the sterilization facility is not sufficient if the package cannot maintain sterility during transportation and storage.

Surgical gloves are normally packed so that the sterile barrier remains intact until the product is opened for use.

Packaging should therefore withstand:

• Sterilization
• Handling
• Carton compression
• International transportation
• Warehouse storage
• The stated shelf life

Seal integrity, package material, sterilization compatibility, and aging performance all matter.

FDA guidance for sterile devices specifically asks manufacturers to describe the packaging used to maintain sterility.

For OEM surgical gloves, changing pouch material or packaging construction should therefore not be treated as a purely cosmetic private-label change.

SAL and Shelf Life Are Connected

A surgical glove may leave the sterilization process at the required SAL, but the sterile claim still needs to remain valid throughout its labeled shelf life.

Shelf-life evaluation should consider both:

Glove performance

Elasticity, tensile strength, barrier integrity, and material condition.

Package performance

Seal integrity and the ability of the sterile barrier system to remain intact.

This is particularly important for export orders that may spend weeks in containers before entering distributor warehouses.

What Should Be Checked Before Ordering Sterile Surgical Gloves?

Before confirming a bulk order, review:

• Surgical glove material
• Sterile status
• Sterilization method
• Required SAL
• Sterilization validation standard
• Sterile barrier packaging
• Shelf life
• Lot traceability
• Applicable physical-property standards
• Regulatory documents for the destination market

For US medical gloves, FDA guidance explicitly identifies SAL 10⁻⁶ for medical glove sterilization.

For other markets, the applicable medical-device regulations and sterilization standards should also be confirmed before shipment.

Do Not Accept “Sterile” as the Complete Specification

A product label stating “STERILE” does not by itself explain how sterility was achieved or maintained.

For surgical glove procurement, a more complete specification should identify:

Sterile Surgical Glove + Validated Sterilization Process + SAL 10⁻⁶ + Sterile Barrier Packaging + Defined Shelf Life

Rayland Medical supplies sterile surgical glove options, including latex and latex-free surgical gloves, and can review sterilization, packaging, product specifications, and destination-market documentation as part of a sourcing project.

For private-label or bulk surgical glove orders, confirming the sterilization route early is especially important because changes to material, packaging, or sterilization method may require additional validation.